Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older of any gender may be considered for this trial.
- People who have diabetes with a blood sugar control measure (A1C) of 7.5 or higher may be eligible.
- People who have had a stent placed in their heart may be eligible.
- People who have had open-heart bypass surgery (CABG) within the last 12 months may be eligible.
- People who have been diagnosed with moderate chronic kidney disease (stages 2 through 4) may be eligible.
- For people who also have heart failure, a hospital stay within one week before joining the trial is required.
Who may not be able to join:
- People who are not willing to sign a consent form agreeing to take part in the trial would not be eligible.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kris Vijay Study Chair, MD, Aventyn, Inc.
Phone: 2317942328
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
CHAPERONE AI Treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.